Chemical formula: C₆₄₇₂H₉₉₆₄N₁₇₂₈O₂₀₁₈S₅₀
Erenumab is indicated for:
Population group: only elderly (65 years old or older)
Erenumab is indicated for prophylaxis of migraine in adults who have at least 4 migraine days per month.
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Erenumab is contraindicated in the following cases:
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
